Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Orthopediatrics (KIDS) Invested Capital (2016 - 2026)

Orthopediatrics has reported Invested Capital over the past 12 years, most recently at $445.4 million for Q1 2026.

  • For Q1 2026, Invested Capital rose 4.91% year-over-year to $445.4 million; the TTM value through Mar 2026 reached $445.4 million, up 4.91%, while the annual FY2025 figure was $452.6 million, 4.76% up from the prior year.
  • Invested Capital for Q1 2026 was $445.4 million at Orthopediatrics, down from $452.6 million in the prior quarter.
  • Over five years, Invested Capital peaked at $458.2 million in Q2 2025 and troughed at $216.1 million in Q1 2022.
  • A 5-year average of $390.4 million and a median of $384.3 million in 2022 define the central range for Invested Capital.
  • Biggest five-year swings in Invested Capital: decreased 3.24% in 2022 and later skyrocketed 73.12% in 2023.
  • Year by year, Invested Capital stood at $379.6 million in 2022, then grew by 2.25% to $388.1 million in 2023, then increased by 11.33% to $432.0 million in 2024, then grew by 4.76% to $452.6 million in 2025, then decreased by 1.6% to $445.4 million in 2026.
  • Business Quant data shows Invested Capital for KIDS at $445.4 million in Q1 2026, $452.6 million in Q4 2025, and $454.6 million in Q3 2025.